Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Return on Sales (2016 - 2025)

Historic Return on Sales for Sunshine Biopharma (SBFM) over the last 10 years, with Q3 2025 value amounting to 0.09%.

  • Sunshine Biopharma's Return on Sales rose 500.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.15% for FY2024, which is 400.0% up from last year.
  • As of Q3 2025, Sunshine Biopharma's Return on Sales stood at 0.09%, which was up 500.0% from 0.19% recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Return on Sales ranged from a high of 7.84% in Q4 2021 and a low of 154.4% during Q1 2021
  • In the last 5 years, Sunshine Biopharma's Return on Sales had a median value of 0.19% in 2025 and averaged 16.5%.
  • Per our database at Business Quant, Sunshine Biopharma's Return on Sales tumbled by -1361500bps in 2021 and then soared by 1443200bps in 2022.
  • Over the past 5 years, Sunshine Biopharma's Return on Sales (Quarter) stood at 7.84% in 2021, then crashed by -176bps to 5.97% in 2022, then soared by 97bps to 0.16% in 2023, then tumbled by -38bps to 0.22% in 2024, then skyrocketed by 58bps to 0.09% in 2025.
  • Its Return on Sales was 0.09% in Q3 2025, compared to 0.19% in Q2 2025 and 0.13% in Q1 2025.